Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

Quantros Accelerates Growth Trajectory with Strategic Investment from Francisco Partners

by Brendon Nafziger, DOTmed News Associate Editor | November 03, 2010

Francisco Partners has considerable experience within the healthcare IT sector. Quantros represents Francisco Partners' seventh investment in the healthcare IT industry, joining its current portfolio of companies - AdvancedMD, API Healthcare, Healthland, QuadraMed, and T-System, as well as a former portfolio company, LYNX Medical Systems, which was acquired by Picis, Inc. in 2007.

B.C. Ziegler and Company acted as financial advisor to Quantros on this transaction.

stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

About Quantros:
Quantros is a leading software and services provider for the healthcare industry in the areas of safety and risk management, quality and performance improvement, accreditation and compliance, real-time surveillance and centralized decision support. Today, more than 2,000 healthcare facilities use Quantros solutions to improve performance and provide a safe, high quality environment of care. For more information about Quantros, please visit www.quantros.com

About Francisco Partners:
With nearly $7.0 billion of committed capital and offices in San Francisco and London, Francisco Partners is one of the world's largest technology-focused private equity funds. The firm was founded to pursue structured investments in technology companies undergoing strategic, technological, and operational change. Francisco Partners targets majority and minority investments in private companies, public companies, and divisions of public companies, with transaction values ranging from $30 million to $2.0 billion. For additional information, please visit www.franciscopartners.com

Back to HCB News